SAS Output

23-JAN-2018 6:10

GI ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1505-Panc,Resect, Perioperative Chemo 1 Y 1 mFOLFIRINOX->Surg->mFOLFIRINOX 112 55 17 17 10 5 1 01/06/2016 309 124
        2 Gem/nab-P->Surg->Gem/nab-P   59 18 17 5 1 0      
            114 35 34 15 6 1      
 
  S1613-mCRC, Adv/Met, TP vs CETIRI 1 Y 0 Screening 130 3 3 3 3 1 1 11/27/2017   61
            3 3 3 3 1 1      
 
Yes A021302-Gastric, Loc Adv, FDG-PET intervention 0 E Total Registrations   2 0 0 0 0 0 06/17/2016    
            2 0 0 0 0 0      
 
  N1048-Rectal,LocalAdv,ChemoRT+/-FOLFOX 1 E Total Registrations   138 31 17 6 3 1 06/05/2013   160
            138 31 17 6 3 1      
 
  R0848-Panc, Adj, Erlotinib v ChemoRT 1 E Total Registrations   20 0 0 0 0 0 01/24/2011   146
            20 0 0 0 0 0      
 
    2 E Total Registrations   5 0 0 0 0 0 01/24/2011    
            5 0 0 0 0 0      
 
No A021501-Adeno Panc,Borderline Resect,Chemo vs ChemoRT 0 E Total Registrations   14 14 11 3 2 0 05/01/2017   81
            14 14 11 3 2 0      
 
    1 E Total Registrations   12 12 10 3 2 0 05/01/2017    
            12 12 10 3 2 0      
 
  EA2133-Anal, local recur/met, Cis+5FU vs Taxol/Carbo 1 E Total Registrations   1 1 0 0 0 0 03/14/2017   42
            1 1 0 0 0 0      
 
  EA2142-GI NEC, Adv G3, EP vs TMZ + CAP 1 E Total Registrations   4 3 2 0 0 0 07/14/2016 197 76
            4 3 2 0 0 0      
 
  NRGGI002-Rectal, Ph II, Sensitization using TNT 1 E Total Registrations   5 5 3 3 1 0 02/21/2017 327 133
            5 5 3 3 1 0      
 

23-JAN-2018 6:10

GI Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S1613 mCRC, Adv/Met, TP vs CETIRI 2 Randomization 09-Oct-17
  3 Crossover 09-Oct-17